Estape, J <br/><br/>
VP 16-213 (VP 16) and cyclophosphamide in the treatment of primitive lung cancer in phase M 1.  [electronic resource] 

 -  Cancer  Jan 1979 
 - 72-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/1097-0142(197901)43:1<72::aid-cncr2820430110>3.0.co;2-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Bone Marrow--drug effects<br/>Cyclophosphamide--administration & dosage<br/>Drug Therapy, Combination<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Podophyllotoxin--analogs & derivatives<br/>Prednisone--administration & dosage<br/>Remission, Spontaneous<br/>Vincristine--administration & dosage